Reviva Pharma Holdings
RVPH
RVPH was delisted on the 13th of May, 2026.
5 hedge funds and large institutions have $3.67K invested in Reviva Pharma Holdings in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 35 closing their positions.
45.38% less ownership
Funds ownership: 45.38% → 0% (-45%)
86% less funds holding
Funds holding: 37 → 5 (-32)
91% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 35
100% less capital inflows, than outflows
Capital inflows: $5.56K | Capital outflows: $2.13M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Miller Global Investments
Dallas,
Texas
|
+$1 |
| 2 |
Mosley Wealth Management
Anaheim,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$579K |
| 2 |
Highbridge Capital Management
New York
|
-$556K |
| 3 |
Armistice Capital
New York
|
-$432K |
| 4 |
GSA Capital Partners
London,
United Kingdom
|
-$191K |
| 5 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
-$85.8K |
RVPH Hedge Fund Activity: Q2 2026 in Review
5 of the 8,393 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharma Holdings (RVPH) for Q2 2026, worth a combined $3.67K — down 100% from $2.13M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of RVPH and 3 opened new positions — a net loss of 32 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Miller Global Investments, opening a new position worth an estimated $1. The largest seller was Millennium Management, exiting entirely with an estimated $579K sold.
- 5 institutional investors held Reviva Pharma Holdings (RVPH) as of Q2 2026, down from 37 in Q1 2026.
- Funds reported $3.67K of Reviva Pharma Holdings stock for Q2 2026, down 100% quarter-over-quarter.
- 3 funds opened new Reviva Pharma Holdings positions in Q2 2026 and 35 closed out, a net change of -32 holders.
- The largest Reviva Pharma Holdings buyer in Q2 2026 was Miller Global Investments, an estimated $1 added.
- The largest Reviva Pharma Holdings seller in Q2 2026 was Millennium Management, an estimated $579K sold.
Based on aggregated 13F filings for Q2 2026.